NQVAX Performance — Nuveen Multi Cap Value Fund, Class A
Data updated: 2026-09-10
NQVAX returned +16.05% year to date and +28.87% over one year to Jun 2026. Annualised returns are +19.10% over 3 years and +13.24% over 5 years. The fund beat its US Mid-Cap Value category average: $100 invested three years ago grew to $169, against $148 for the category, and to $129 over one year, against $120. Volatility over the past three years was 12.25% a year. In the 12 months to Jun 2026 the fund took in a net $511.4M, and assets reached $1.26B.
NQVAX Growth of $100
What $100 invested in Nuveen Multi Cap Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | NQVAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $129 | $120 |
| 3 years (Jul 2023 – Jun 2026) | $169 | $148 |
| 5 years (Jul 2021 – Jun 2026) | $186 | $154 |
| Since data start (Jul 2019 – Jun 2026) | $248 | $212 |
NQVAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +16.05% |
| 1 year | +28.87% |
| 3 years (annualised) | +19.10% |
| 5 years (annualised) | +13.24% |
NQVAX Annual Returns
Calendar-year total returns of Nuveen Multi Cap Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +16.05% |
| 2025 | +16.20% |
| 2024 | +18.96% |
| 2023 | +15.65% |
| 2022 | −1.29% |
| 2021 | +28.22% |
| 2020 | −0.53% |
| 2019 (Jul–Dec) | +5.95% |
NQVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.5% | +2.7% | −4.0% | +8.9% | +1.3% | +2.1% | — | — | — | — | — | — |
| 2025 | +4.2% | −0.7% | −3.6% | −4.0% | +4.5% | +4.5% | +2.3% | +2.8% | +0.5% | +1.5% | +2.1% | +1.4% |
| 2024 | −0.5% | +2.1% | +6.4% | −3.8% | +4.5% | +0.7% | +3.7% | +1.7% | +1.3% | +0.1% | +7.4% | −5.4% |
| 2023 | +6.9% | −1.0% | −2.6% | +0.9% | −1.3% | +6.8% | +3.3% | −2.3% | −3.7% | −2.9% | +6.2% | +5.0% |
| 2022 | −1.0% | +2.2% | +2.9% | −6.6% | +1.7% | −8.9% | +6.7% | −1.3% | −8.0% | +12.8% | +5.2% | −4.6% |
| 2021 | +2.3% | +9.8% | +5.5% | +5.5% | +2.3% | −1.3% | −0.5% | +1.1% | −3.2% | +3.9% | −4.2% | +4.9% |
| 2020 | −5.3% | −9.4% | −21.8% | +13.0% | +4.6% | +0.3% | +1.8% | +4.8% | −3.6% | +0.1% | +15.3% | +5.4% |
| 2019 | — | — | — | — | — | — | +0.7% | −6.0% | +5.7% | +0.8% | +2.2% | +2.8% |
NQVAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 12.25%
- 3-year Sharpe ratio: 1.19 (vs 4.5% risk-free rate)
- Best month: +8.91% (Apr 2026)
- Worst month: −5.40% (Dec 2024)
NQVAX Fund Flows
Monthly money in and out of Nuveen Multi Cap Value Fund, from SEC Form N-PORT.
- 12-month net flow: $511.4M
- 12-month gross sales (incl. reinvestments): $578.3M
- Sales ÷ redemptions: 8.65×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $19.5M | $14.6M | $4.9M |
| May 2026 | $21.7M | $9.6M | $12.1M |
| Apr 2026 | $44.2M | $3.4M | $40.9M |
| Mar 2026 | $34.3M | $13.4M | $20.9M |
| Feb 2026 | $65.9M | $4.2M | $61.7M |
| Jan 2026 | $69.9M | $4.6M | $65.3M |
| Dec 2025 | $70.6M | $3.5M | $67.1M |
| Nov 2025 | $61.3M | $3.5M | $57.8M |
| Oct 2025 | $57.6M | $2.0M | $55.6M |
| Sep 2025 | $47.1M | $2.1M | $45.0M |
| Aug 2025 | $57.6M | $4.1M | $53.6M |
| Jul 2025 | $28.5M | $1.8M | $26.7M |
NQVAX Assets Under Management
Net assets of Nuveen Multi Cap Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.26B |
| 2026-03-31 | $1.06B |
| 2025-12-31 | $889.17M |
| 2025-09-30 | $684.31M |
| 2025-06-30 | $520.23M |
| 2025-03-31 | $458.94M |
| 2024-12-31 | $498.03M |
| 2024-09-30 | $525.28M |
| 2024-06-30 | $481.36M |
| 2024-03-31 | $404.21M |
| 2023-12-31 | $284.06M |
| 2023-09-30 | $182.96M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.